since the efficacy of the pulse actinomycin d therapy for good-prognosis , postmolar trophoblastic disease is similar to that of the traditional 5-day regimens , it is concluded that it is the treatment of choice because of its greater convenience and lower cost .
C0010934
actinomycin d
C2931618
trophoblastic disease